Latest Updates

Interview

Diasome's Liver Targeted Insulin with Robert Geho

April 18, 2019

Share this article
Interview

Latest Updates

News

Press Release

Diasome's CMO, Dr. Marc Penn, to Unveil Innovative Diabetes Research at ADA Scientific Sessions

View Article
Study

Divergent Hypoglycemic Effects of Hepatic-Directed Prandial Insulin: A 6-Month Phase 2b Study in Type 1 Diabetes

View Article
Journal

Could Aiming Insulin at the Liver Be an Answer to Using Less?

View Article
View All